There is no experience with overdose in clinical trials with ROZLYTREK. Patients who experience overdose should be closely supervised and supportive care instituted. There are no known antidotes for ROZLYTREK.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
